<PAGE> 1
AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON FEBRUARY 11, 1997
REGISTRATION NO. 333-
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
------------------------
FORM S-1
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
------------------------
BIOSITE DIAGNOSTICS INCORPORATED
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
<TABLE>
<S> <C> <C>
DELAWARE 3826 33-0288606
(STATE OR OTHER JURISDICTION OF (PRIMARY STANDARD INDUSTRIAL (I.R.S. EMPLOYER IDENTIFICATION NO.)
INCORPORATION OR ORGANIZATION CLASSIFICATION CODE NUMBER)
</TABLE>
11030 ROSELLE STREET, SAN DIEGO, CALIFORNIA 92121
(619) 455-4808
(ADDRESS, INCLUDING ZIP CODE, AND TELEPHONE NUMBER, INCLUDING AREA CODE,
OF REGISTRANT'S PRINCIPAL EXECUTIVE OFFICES)
------------------------
KIM D. BLICKENSTAFF
PRESIDENT AND CHIEF EXECUTIVE OFFICER
BIOSITE DIAGNOSTICS INCORPORATED
11030 ROSELLE STREET
SAN DIEGO, CALIFORNIA 92121
(619) 455-4808
(NAME, ADDRESS, INCLUDING ZIP CODE, AND TELEPHONE NUMBER,
INCLUDING AREA CODE, OF AGENT FOR SERVICE OF PROCESS)
------------------------
COPIES TO:
<TABLE>
<S> <C>
THOMAS E. SPARKS, JR., ESQ. ALAN C. MENDELSON, ESQ.
JOHN L. DONAHUE, ESQ. D. BRADLEY PECK, ESQ.
GEORGE A. GUCKER, ESQ. NANCY E. DENYES, ESQ.
PILLSBURY MADISON & SUTRO LLP COOLEY GODWARD LLP
P.O. BOX 7880 4365 EXECUTIVE DRIVE, SUITE 1100
SAN FRANCISCO, CA 94120-7880 SAN DIEGO, CA 92121-2128
</TABLE>
------------------------
APPROXIMATE DATE OF COMMENCEMENT OF PROPOSED SALE TO THE PUBLIC:
As soon as practicable after this Registration Statement becomes effective.
If any of the securities being registered on this Form are to be offered on
a delayed or continuous basis pursuant to Rule 415 under the Securities Act of
1933 check the following box. [ ]
If this Form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, please check the following box
and list the Securities Act registration statement number of the earlier
effective registration statement for the same offering. [X] 333-17657
If this Form is a post-effective amendment filed pursuant to Rule 462(c)
under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. [ ]
If delivery of the prospectus is expected to be made pursuant to Rule 434,
please check the following box. [ ]
------------------------
CALCULATION OF REGISTRATION FEE
<TABLE>
<S> <C> <C> <C> <C>
- ----------------------------------------------------------------------------------------------------------
- ----------------------------------------------------------------------------------------------------------
PROPOSED PROPOSED
MAXIMUM MAXIMUM
TITLE OF EACH CLASS OF SECURITIES AMOUNT TO BE OFFERING PRICE AGGREGATE AMOUNT OF
TO BE REGISTERED REGISTERED(1) PER SHARE(2) OFFERING PRICE(2) REGISTRATION FEE
- ----------------------------------------------------------------------------------------------------------
Common Stock, $.01 par value...... 460,000 shares $12.00 $5,520,000 $1,673
- ----------------------------------------------------------------------------------------------------------
- ----------------------------------------------------------------------------------------------------------
</TABLE>
(1) Includes 60,000 shares that the Underwriters have the option to purchase to
cover over-allotments, if any.
(2) Estimated solely for the purpose of computing the registration fee pursuant
to Rule 457(a).
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
<PAGE> 2
INCORPORATION OF CERTAIN INFORMATION BY REFERENCE
This Registration Statement is filed with the Securities and Exchange
Commission (the "Commission") under the Securities Act of 1933, as amended (the
"Act") by Biosite Diagnostics Incorporated (the "Company"), pursuant to Rule
462(b) under the Act. This Registration Statement incorporates by reference the
contents of the Registration Statement on Form S-1 (File No. 333-17657) relating
to the offering of up to 2,300,000 shares of Common Stock of the Company.
CERTIFICATION
The Company hereby certifies to the Commission that (i) it has instructed
its bank to pay the Commission the filing fee set forth on the cover page of
this Registration Statement by a wire transfer of such amount to the
Commission's account at Mellon Bank as soon as practicable (but no later than
the close of business on February 12, 1997), (ii) it will not revoke such
instructions, (iii) it has sufficient funds in the relevant account to cover the
amount of such filing fee, and (iv) it will confirm receipt of such instructions
by the bank during regular business hours on February 12, 1997.
2
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-1, and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of San Diego, State of California, on February 11, 1997.
BIOSITE DIAGNOSTICS
INCORPORATED
By: /s/ Christopher J. Twomey
------------------------------------
Christopher J. Twomey
Vice President, Finance and Chief
Financial Officer
<TABLE>
<CAPTION>
NAME TITLE DATE
- ----------------------------------------------- ------------------------- ------------------
<S> <C> <C>
/s/ Kim D. Blickenstaff* President, Chief February 11, 1997
- ----------------------------------------------- Executive Officer
Kim D. Blickenstaff (Principal Executive
Officer) and Director
/s/ Christopher J. Twomey Vice President and Chief February 11, 1997
- ----------------------------------------------- Financial Officer
Christopher J. Twomey (Principal Financial
Officer and Accounting
Officer)
/s/ Timothy J. Wollaeger* Chairman of the Board February 11, 1997
- -----------------------------------------------
Timothy J. Wollaeger
/s/ Gunars E. Valkirs, Ph.D.* Director February 11, 1997
- -----------------------------------------------
Gunars E. Valkirs, Ph.D.
/s/ Thomas H. Adams, Ph.D.* Director February 11, 1997
- -----------------------------------------------
Thomas H. Adams
/s/ Howard E. Greene, Jr.* Director February 11, 1997
- -----------------------------------------------
Howard E. Greene
/s/ Frederick J. Dotzler* Director February 11, 1997
- -----------------------------------------------
Frederick J. Dotzler*
/s/ Stephen K. Reidy* Director February 11, 1997
- -----------------------------------------------
Stephen K. Reidy*
/s/ Jesse I. Treu, Ph.D.* Director February 11, 1997
- -----------------------------------------------
Jesse I. Treu, Ph.D.
*By: /s/ Christopher J. Twomey
- -----------------------------------------------
Christopher J. Twomey
Attorney-in-Fact
</TABLE>
3
<PAGE> 4
EXHIBIT INDEX
<TABLE>
<CAPTION>
EXHIBIT SEQUENTIALLY
NUMBER DESCRIPTION OF DOCUMENT NUMBERED PAGE
- ------ ----------------------------------------------------------------------- -------------
<C> <S> <C>
5.1 Opinion of Pillsbury Madison & Sutro LLP (incorporated by reference to
Exhibit 5.1 to the Registrant's Registration Statement on Form S-1
(File No. 333-17657))
23.1 Consent of Ernst & Young LLP, Independent Auditors
23.2 Consent of Pillsbury Madison & Sutro LLP (included in its opinion
incorporated by reference to Exhibit 5.1 to the Registrant's
Registration Statement on Form S-1 (File No. 333-17657))
</TABLE>
<PAGE> 1
EXHIBIT 23.1
CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS
We consent to the reference to our firm under the captions "Experts" and
"Selected Financial Data" and to the use of our report dated November 12, 1996,
except for Note 7, as to which the date is December 5, 1996, included in
Amendment No. 5 to Registration Statement (Form S-1 No. 333-17657) and related
Prospectus of Biosite Diagnosis Incorporated for the registration of 460,000
shares of its common stock.
/s/ ERNST & YOUNG LLP
ERNST & YOUNG LLP
San Diego, California
February 11, 1997
